The estimated Net Worth of Patrick J Balthrop is at least $2.77 Milione dollars as of 20 May 2020. Mr. Balthrop owns over 4,000 units of Personalis Inc stock worth over $23,800 and over the last 20 years he sold PSNL stock worth over $2,599,940. In addition, he makes $150,653 as Independent Director at Personalis Inc.
Sign up
Mr. Balthrop PSNL stock SEC Form 4 insiders trading
Patrick has made over 13 trades of the Personalis Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of PSNL stock worth $49,920 on 20 May 2020.
The largest trade he's ever made was exercising 151,565 units of Personalis Inc stock on 5 August 2013 worth over $1,530,807. On average, Patrick trades about 10,845 units every 108 days since 2004. As of 20 May 2020 he still owns at least 4,000 units of Personalis Inc stock.
You can see the complete history of Mr. Balthrop stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Patrick Balthrop biography
Patrick J. Balthrop Sr. serves as Independent Director of the Company. Mr. Balthrop has served on the board of directors of Oxford Immunotec Global PLC, a diagnostics company. Since January 2015, Mr. Balthrop has been the Founding Principal of Apalachee Ventures, LLC, an investment and advisory firm. From September 2004 to October 2014, Mr. Balthrop served on the board of directors and as Chief Executive Officer, President, and Director of Luminex Corporation, a diagnostics, tools, and devices company. Mr. Balthrop holds a B.S. in Biology from Spring Hill College and an M.B.A. from the Kellogg School of Management at Northwestern University. Mr. Balthrop was selected to serve on our board of directors because of his management experience in the healthcare and medical device industry.
What is the salary of Patrick Balthrop?
As the Independent Director of Personalis Inc, the total compensation of Patrick Balthrop at Personalis Inc is $150,653. There are 14 executives at Personalis Inc getting paid more, with Aaron Tachibana having the highest compensation of $3,003,510.
How old is Patrick Balthrop?
Patrick Balthrop is 63, he's been the Independent Director of Personalis Inc since 2015. There are 5 older and 9 younger executives at Personalis Inc. The oldest executive at Personalis Inc is A. Blaine Bowman, 73, who is the Independent Director.
What's Patrick Balthrop's mailing address?
Patrick's mailing address filed with the SEC is C/O OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, ABINGDON, OXFORDSHIRE, X0, OX14 4RZ.
Insiders trading at Personalis Inc
Over the last 5 years, insiders at Personalis Inc have traded over $56,423,548 worth of Personalis Inc stock and bought 5,708,990 units worth $54,066,334 . The most active insiders traders include Llp Abingworth, Paul Ricci e Ai, Inc. Tempus. On average, Personalis Inc executives and independent directors trade stock every 15 days with the average trade being worth of $410,996. The most recent stock trade was executed by Ai, Inc. Tempus on 16 August 2024, trading 3,500,000 units of PSNL stock currently worth $17,745,000.
What does Personalis Inc do?
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
What does Personalis Inc's logo look like?
Complete history of Mr. Balthrop stock trades at Luminex Corp, Oxford Immunotec Global PLC e Personalis Inc
Personalis Inc executives and stock owners
Personalis Inc executives and other stock owners filed with the SEC include:
-
Aaron Tachibana,
Chief Financial Officer -
Clinton Musil,
Chief Business Officer -
John Stephen West,
Co-Founder, CEO, Pres & Director -
Paul Ricci,
Independent Director -
John West,
President, Chief Executive Officer, Director -
Dr. Richard Chen M.D., M.S., MS,
Sr. VP of R&D and Chief Medical Officer -
Richard Chen,
Chief Science Officer -
Aaron L. Tachibana,
Sr. VP & CFO -
Dr. Richard Chen M.S., M.D., MS,
Chief Scientific Officer -
A. Blaine Bowman,
Independent Director -
Alan Colowick,
Independent Director -
Karin Eastham,
Independent Director -
Jonathan MacQuitty,
Independent Chairman of the Board -
Kenneth Ludlum,
Independent Director -
Patrick Balthrop,
Independent Director -
Stephen Moore,
General Counsel -
Dr. Euan A. Ashley DPHIL, FRCP, M.D., Ph.D.,
Co-Founder and Member of Clinical & Scientific Advisory Board -
Prof. Russ B. Altman M.D., Ph.D.,
Co-Founder and Member of Clinical & Scientific Advisory Board -
Michael J. Fitzpatrick,
VP of Worldwide Sales -
Stephen M. Moore J.D.,
VP, Gen. Counsel & Corp. Sec. -
Carol J. Tillis,
VP of Fin. & Admin. -
Dr. Michael Snyder Ph.D.,
Co-Founder and Member of Clinical & Scientific Advisory Board -
Dr. Atul Butte,
Co-Founder and Member of Clinical & Scientific Advisory Board -
Dr. Euan A. Ashley M.D., Ph.D., FRCP, DPHIL,
Co-Founder and Member of Clinical & Scientific Advisory Board -
Prof. Russ B. Altman,
Co-Founder and Member of Clinical & Scientific Advisory Board -
Kenneth J Widder,
-
Olivia Kyusuk Bloom,
-
Ken Ludlum,
Director -
Mdv Partners, L.L.C.Mdv Ix ...,
-
Venture Partners Viii Lp Li...,
-
Venture Partners Select Iv,...,
-
Llp Abingworth,
-
Christopher M Hall,
PRESIDENT AND CEO -
Venture Partners Select Iv,...,
-
Ai, Inc. Tempus,
10% owner -
Lonnie Shoff,